Nationwide Recall of Children’s Ibuprofen Due to Contamination

Nearly 90,000 bottles of children’s ibuprofen oral suspension have been recalled nationwide due to potential contamination, the Food and Drug Administration (FDA) announced. The recall impacts a generic product and does not include brand-name ibuprofen such as Advil or Motrin.

What’s Being Recalled?

The recall involves 4-ounce bottles of Children’s Ibuprofen Oral Suspension manufactured for Taro Pharmaceuticals by Strides Pharma Inc. . Specifically, bottles with lot numbers 7261973A and 7261974A and an expiration date of January 31, 2027, are affected. The recall number is D-0390-2026.

Why is the Ibuprofen Being Recalled?

The recall was initiated after reports of contamination. Consumers have reported finding a gel-like substance and black particles in the medication. This issue has been classified as a Class II recall, meaning the product could cause temporary or medically reversible health effects.

What Should Consumers Do?

The FDA urges consumers to immediately stop using any affected product and check their medication for the specified lot numbers and expiration date. Consumers should contact their healthcare provider if they have concerns about potential adverse effects.

What is a Class II Recall?

A Class II recall, as defined by the FDA, indicates that the use of or exposure to the product may cause temporary or medically reversible health consequences, or the probability of serious adverse health consequences is remote.

Additional Information

The recall was voluntarily initiated by Strides Pharma Inc. . Consumers can find more information on the FDA website or by contacting Strides Pharma directly.